机构

• 上海药物研究所 [55]
• 广州生物医药与健康研... [2]
• 昆明植物研究所 [2]
• 合肥物质科学研究院 [2]
• 大连化学物理研究所 [1]
• 上海应用物理研究所 [1]
• 更多

采集方式

• OAI收割 [65]
• iSwitch采集 [1]

内容类型

• 期刊论文 [63]
• 学位论文 [2]
• 会议论文 [1]

发表日期

• 2024 [2]
• 2023 [6]
• 2022 [9]
• 2021 [5]
• 2020 [9]
• 2019 [4]
• 更多

学科主题

• 生物化学与分子生物学 [2]
• Biochemist... [1]
• Oncology [1]
• Research &... [1]

筛选

浏览/检索结果: 共66条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer 期刊论文  OAI收割 ADVANCED MATERIALS, 2024, 页码: 12 作者:  Zhang, Shunan;  Lai, Yi;  Pan, Jiaxing;  Saeed, Madiha;  Li, Shiqin   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/09 active tumor targeting  nanosensitizer  PROTAC prodrug  radiation therapy  tumor microenvironment   Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 265, 页码: 14 作者:  Chen, Xuetao;  Wu, Tingting;  Du, Zhiyan;  Kang, Wenjing;  Xu, Rujun   |  收藏  |  浏览/下载：20/0  |  提交时间：2024/02/27 BET  BD1  Bromodomain  Brain-permeable  Multiple sclerosis   Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 262, 页码: 18 作者:  Zhang, Jingyu;  Duan, Haiting;  Gui, Renzhao;  Wu, Mingfei;  Shen, Liteng   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/12/19 Acute myeloid leukemia  Bromodomain-containing protein 9  Proteolysis-targeting chimera  Orally bioavailable  Docking   Design, Construction, and Screening of Diversified Pyrimidine-Focused DNA-Encoded Libraries 期刊论文  OAI收割 ACS MEDICINAL CHEMISTRY LETTERS, 2023, 卷号: 14, 期号: 8, 页码: 1073-1078 作者:  Seydimemet, Mengnisa;  Yang, Yixuan;  Lv, Yuhan;  Liu, Jiaxiang;  Yan, Ziqin   |  收藏  |  浏览/下载：14/0  |  提交时间：2023/10/17 DNA-encoded library technology  Pyrimidine-focusedDNA-encodedlibrary  BRD4  Affinity screening  Inhibitor   Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 13, 页码: 8725-8744 作者:  Chen, Xuetao;  Cao, Danyan;  Liu, Chihong;  Meng, Fanying;  Zhang, Zijian   |  收藏  |  浏览/下载：9/0  |  提交时间：2023/10/17 Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 254, 页码: 17 作者:  Yan, Ziqin;  Lyu, Xilin;  Lin, Dongze;  Wu, Gaoxing;  Gong, Yang   |  收藏  |  浏览/下载：25/0  |  提交时间：2023/10/17 Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injury 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 247, 页码: 13 作者:  Chen, Chao;  Lu, Tian;  Chen, Panyu;  Li, Zizhou;  Yang, Yaxi   |  收藏  |  浏览/下载：23/0  |  提交时间：2023/04/10 BET Bromodomains  Acute liver injury  Anti-inflammatory activity  Inhibitors  Tetracyclic compounds   Design, synthesis, and biological evaluation of BRD4 degraders 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 卷号: 78, 页码: 12 作者:  Ding, Mengyuan;  Shao, Yingying;  Sun, Danwen;  Meng, Suorina;  Zang, Yi   |  收藏  |  浏览/下载：19/0  |  提交时间：2023/04/10 PROTAC  BRD4 degradation  Leukemia  Multiple myeloma  Pulmonary fibrosis   In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy 期刊论文  OAI收割 NANO TODAY, 2022, 卷号: 47, 页码: 11 作者:  Hou, Bo;  Ye, Jiayi;  Li, Junhao;  Xu, Zhiai;  Yu, Haijun   |  收藏  |  浏览/下载：29/0  |  提交时间：2023/04/10 Immune-excluded tumor  Extracellular matrix  In-situ click reaction  Prodrug nanoparticles  Immune resistance   Design and development of a novel series of oral bivalent BET inhibitors with potent anticancer activities 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 239, 页码: 13 作者:  Luo, Menglan;  Wu, Qian;  Yang, Yueyue;  Sun, Lin;  Huan, Xiajuan   |  收藏  |  浏览/下载：40/0  |  提交时间：2022/08/30 BET inhibitor  BRD4  Bivalent inhibitor  Anticancer